|
INTS9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.634200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.225970E-01 |
| Normal-vs-Stage2 |
5.282200E-01 |
| Normal-vs-Stage3 |
9.199200E-01 |
| Normal-vs-Stage4 |
6.474400E-02 |
| Stage1-vs-Stage2 |
8.596000E-01 |
| Stage1-vs-Stage3 |
4.661200E-01 |
| Stage1-vs-Stage4 |
2.164200E-01 |
| Stage2-vs-Stage3 |
6.970000E-01 |
| Stage2-vs-Stage4 |
1.988030E-01 |
| Stage3-vs-Stage4 |
1.371030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.085400E-01 |
| Normal-vs-AfricanAmerican |
5.570000E-02 |
| Normal-vs-Asian |
2.298900E-03 |
| Caucasian-vs-AfricanAmerican |
2.790200E-01 |
| Caucasian-vs-Asian |
2.009000E-01 |
| AfricanAmerican-vs-Asian |
2.183400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.576400E-02 |
| Normal-vs-Female |
9.961200E-01 |
| Male-vs-Female |
1.873850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.889500E-02 |
| Normal-vs-Extreme_Weight |
2.402000E-01 |
| Normal-vs-Obese |
4.603600E-01 |
| Normal-vs-Extreme_Obese |
2.928200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.703200E-01 |
| Normal_Weight-vs-Obese |
3.772800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.061000E-01 |
| Extreme_Weight-vs-Obese |
7.343600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.810000E-01 |
| Obese-vs-Extreme_Obese |
4.394600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.449000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.843800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.927700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.91939999999646E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.983000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.517800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.324200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.110630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.442800E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.255790E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.325500E-02 |
| Normal-VS-Type2 PRCC |
1.958830E-01 |
| Normal-VS-KIRP CIMP |
3.413400E-01 |
| Normal-VS-Unclassified PRCC |
4.336000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.467800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.785600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.094410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.497400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.230780E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.928800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.007000E-01 |
| Normal-vs-N1 |
1.019430E-01 |
| Normal-vs-N2 |
8.682000E-01 |
| N0-vs-N1 |
3.794800E-01 |
| N0-vs-N2 |
7.722200E-01 |
| N1-vs-N2 |
6.312000E-01 |
|
|
